Is 2026 the Year the Housing Market Finally Roars Back? NAR Thinks So

After several sluggish years that tested the patience of brokers, buyers, and everyone in between, the National Association of REALTORS® is sending an optimistic signal across the industry. According to newly released projections, 2026 may be the long‑awaited comeback year—one marked by rising sales, stabilizing rates, and renewed market confidence.

Nar conference speaker

A Forecast Worth Noting: 14% Sales Growth

NAR Chief Economist Lawrence Yun is calling for a notable 14% increase in nationwide home sales for 2026, signaling real movement after the flat conditions seen throughout 2025. New‑home sales are also projected to climb 5% next year. Importantly, Yun emphasizes that these gains are not expected to compromise home values—NAR forecasts a steady 4% price increase nationwide.

“You can finally measure the lift next year,” Yun explained at the NAR NXT Residential Economic Issues & Trends Forum, adding that job growth and persistent inventory shortages will continue to support home prices.

Momentum Is Already Here

Several early indicators are pointing toward a healthier market ahead. Mortgage applications have stayed consistently above last year’s levels—with a striking 31% year‑over‑year surge in recent weeks. Job gains remain steady, builders are adding supply, and markets have stabilized following the extended 43‑day government shutdown.

Mortgage Rates: Relief, Even If Only Slight

Rates remain a major hurdle for many buyers, but there’s progress. After entering the year near 7%, the 30‑year fixed now sits at 6.24%. Yun expects 2026 to average around 6%—not a dramatic drop, but enough to unlock pent‑up demand. While ultra‑low rates may not return soon, even modest shifts can reignite buyer momentum.

A Market Divided: The “Haves” and “Have‑Nots”

Today’s market is far from uniform. Higher‑priced homes—particularly those in the $750,000 to $1 million bracket—are moving quickly thanks to healthier inventory and confident buyers. Lower‑priced homes, however, remain scarce, fueling ongoing affordability concerns.

NAR Deputy Chief Economist Jessica Lautz outlined the widening divide between well‑positioned repeat buyers and first‑time buyers facing student loans, childcare costs, and rising rents. First‑time buyers now represent only 21% of the market—an all‑time low compared to their historic norm of 40%.

Pricing Reality: Reductions Are Back

As listings linger, sellers are rediscovering the importance of realistic pricing. MLS data shows predictable price‑reduction trends based on days on market:

  • 0–14 days: 4.9%
  • 15–30 days: 6.1%
  • 31–60 days: 7.3%
  • 61–90 days: 9%
  • 91–120 days: 10.6%
  • 120+ days: 13.8%

While some markets may experience temporary dips due to surging inventory, national pricing remains stable. NAR projects a 3% median price increase in 2025 and 4% in 2026.

The Bigger Picture: Fundamentals Remain Strong

Despite occasional concerns over rising foreclosures, the broader data remains encouraging: serious delinquencies are near historic lows, homeowners maintain strong equity, and job growth continues across major industries.

In short, the foundation is steady. With easing mortgage rates and rising applications, NAR believes 2026 could be a pivotal year for real estate professionals nationwide.

What This Means for Professionals—and Aspiring Agents

A rebounding market means opportunity. Whether you’re currently practicing or preparing to enter the field, staying ahead of these trends positions you for success. For aspiring real estate professionals, now is the ideal time to complete your education so you’re fully licensed by the time the surge hits.

If you’re working toward your real estate license—or branching into mortgage, insurance, or other professional fields—Cameron Academy’s flexible online programs help you stay competitive, knowledgeable, and career‑ready as the next market cycle begins.

Source: Explore NAR’s full 2026 outlook at https://www.nar.realtor.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.